Morgan Stanley’s Reunion Neuroscience Inc. Common Shares REUN Stock Holding History

Morgan Stanley’s Portfolio REUN Stock Details REUN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,695	Closed	-$4.17K	–	7814
2023 Q2	$4.17K	Buy	3,695 +2,752	+292%	+$2.34K	﹤0.01%	7027
2023 Q1	$651	Buy	943 +200	+27%	+$223	﹤0.01%	7404
2022 Q4	$669	Hold	743	–	–	﹤0.01%	7528
2022 Q3	$1K	Hold	743	–	–	﹤0.01%	7647
2022 Q2	$3K	Sell	743 -20	-3%	-$100	﹤0.01%	7549
2022 Q1	$5K	Sell	763 -21,807	-97%	-$181K	﹤0.01%	7606
2021 Q4	$277K	Sell	22,570 -862	-4%	-$18.5K	﹤0.01%	5885
2021 Q3	$538K	Buy	+23,432	New	+$590K	﹤0.01%	5447

Morgan Stanley's REUN Position: Q3 2023 in Review

Morgan Stanley sold out of Reunion Neuroscience Inc. Common Shares (REUN) in Q3 2023, closing a stake of 3,695 shares — an estimated $4.17K sold.

Morgan Stanley first reported a position in REUN in Q3 2021 and held it in 8 quarters. The position peaked at $538K in Q3 2021. 0 funds tracked by Wall St. Rank hold REUN as of Q3 2023.

Morgan Stanley reported no remaining Reunion Neuroscience Inc. Common Shares position as of Q3 2023 after selling out during the quarter.
Morgan Stanley sold 3,695 Reunion Neuroscience Inc. Common Shares shares in Q3 2023, an estimated $4.17K.
Morgan Stanley first reported a position in Reunion Neuroscience Inc. Common Shares in Q3 2021 and held it in 8 quarters.
Morgan Stanley's Reunion Neuroscience Inc. Common Shares position peaked at $538K in Q3 2021.
0 funds tracked by Wall St. Rank held Reunion Neuroscience Inc. Common Shares as of Q3 2023.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.